The OJC Meets Julie McCrossin AM
The Oncology Podcast, brought to you by oncologynews.com.au, is proud to present the latest episode in…
Browsing: Featured
New meta-analysis: Planning for patients with high-risk prostate cancer
Results of a large study led by UCLA Jonsson Comprehensive Cancer Center, USA, researchers could…
Tackling racial disparities in prostate cancer
Prostate cancer is the second deadliest cancer in men in the United States. The incidence…
Genetics and availability of treatments influence the management of head and neck cancer in Asia
The Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines was presented at the ESMO Asia…
What is the impact of first-line nivolumab on subsequent therapy choices for metastatic gastric cancer?
Knock-on effects of early immune checkpoint inhibitor use stimulate consideration of alternative approaches for further…
New data for management of hepatocellular carcinoma
The COSMIC-312 trial met its primary endpoint of progression-free survival, but interim overall survival results…
Should renal cell carcinomas be managed differently in Asia?
The Pan-Asian adaptation of the ESMO guidelines introduces some changes to the standard of care…
December 2021 update from Te Aho o Te Kahu, Cancer Control Agency New Zealand
I orea te tautara ka puta ki waho. A problem is solved by continuing to…
Cancer-spotting AI vulnerable to cyberattacks
Artificial intelligence (AI) models that evaluate medical images have potential to speed up and improve…
The OJC Meets Andrew Denton
The Oncology Podcast, brought to you by oncologynews.com.au, is proud to present the latest episode in…